Angels Partners logo
  • Find Angel Investors
    • Find Angel Investors in the US
    • Find Angel Investors in the UK
    • Find Angel Investors in Europe
      Find Angel Investors in DenmarkFind Angel Investors in FinlandFind Angel Investors in FranceFind Angel Investors in GermanyFind Angel Investors in ItalyFind Angel Investors in NetherlandsFind Angel Investors in SwedenFind Angel Investors in Switzerland
    • Find Angel Investors in Canada
    • Find Angel Investors in Australia
  • Top VC Firms
    Top AI VC firmsTop BioTech VC firmsTop CleanTech VC firmsTop Cyber Security VC firmsTop E-commerce VC firmsTop HealthTech VC firmsTop FinTech VC firmsTop Food Industry VC firmsTop Robotics VC firmsTop SaaS VC firmsTop Transportation VC firms
  • Pricing
  • Products
    Investor CommunityInvestor DatabaseAutomationWarm IntrosFounder CommunityDocument SharingLegal Templates
  • FAQ
  • Blog
  • About
  • Sign up
  • Log in
Are you an

  • Entrepreneur
  • Investor
< Browse Firms
Logo Firm CureDuchenne Ventures
google

CureDuchenne Ventures

map marker logo  |  U.S.A.

Investor TypeFirm
IndustriesLife Science

Investors who are part of this firm

About The Fund

CureDuchenne Ventures is the corporate venture arm of CureDuchenne, a nonprofit organization with a distinct focus on finding and funding cure research for Duchenne muscular dystrophy. Since its inception in 2014, CureDuchenne Ventures has been instrumental in supporting the biotech and pharmaceutical sectors, specifically targeting companies that are pioneering advancements in the life sciences with potential therapeutic applications for neuromuscular diseases. Their investment thesis revolves around identifying innovative research and companies that have the potential to halt the progression of, or cure, Duchenne muscular dystrophy—a genetic disorder characterized by progressive muscle degeneration and weakness. By leveraging a strategic investment approach, they seek to catalyze scientific breakthroughs that can translate into improved health outcomes. CureDuchenne Ventures not only provides capital but also extends value-added support to their portfolio companies through the broader network and resources of the parent organization. Their mission encapsulates fostering collaborations that bridge the gap between laboratory research and drug development, thus accelerating access to transformative therapies for those affected by Duchenne muscular dystrophy. Their commitment to innovation and patient health drives a portfolio strategy that emphasizes not only financial return but also therapeutic impact, with the ultimate goal of delivering real and meaningful advancements in treatment options for patients suffering from this condition.

CureDuchenne Ventures's investments on record

Shape Therapeutics €35,500,000.00 Later stage VC

Similar Investment Firms

Similar Investor Partners For Growth
Partners For Growth
Similar Investor Questmark Partners
Questmark Partners
Similar Investor Denovo Ventures
Denovo Ventures
Similar Investor Next Chapter Holdings Lp
Next Chapter Holdings Lp
Similar Investor Software Holding & Finance
Software Holding & Finance
Similar Investor Marsbio Management
Marsbio Management
Similar Investor AshHill Biomedical
AshHill Biomedical
Similar Investor UAVenture Capital
UAVenture Capital
Similar Investor Riverfront Ventures
Riverfront Ventures
angels partners Overview

Contact over 100,000 investors!

Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.

With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.

View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.

e We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.

 

Register to become visible to a large community of investors on our platform.

  • Sign up
  • Log in
  • Prime Founders
  • 85 Great Portland St.
  • London, U.K.
  •   contact@angelspartners.com
  • About Us
  • Terms & Conditions
  • Privacy Policy
  • Editorial Process
  • Contact Us
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 daysproof logo